Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Jiawei Xiangru Oral Liquid is a Traditional Chinese Medicine (TCM) formulation developed by the Hunan Provincial Institute of Traditional Chinese Medicine. It is primarily indicated for the treatment of the common cold, specifically the "summer heat-dampness" type (暑湿感冒). The preparation is a modification of the classic TCM formula "Xiangru San," which traditionally consists of *Elsholtzia ciliata* (Xiangru), *Magnolia officinalis* (Houpo), and *Lablab purpureus* (Baibiandou). Jiawei Xiangru Oral Liquid works by inducing diaphoresis to dispel summer heat, resolving dampness, and harmonizing the middle jiao (spleen and stomach). It is commonly used to alleviate symptoms such as fever, chills, headache, abdominal pain, and diarrhea that occur during the summer months.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on jiawei xiangru oral liquid.